Abstract
Since its inception as a diagnostic entity, attempts have been made to divide schizophrenia into homogeneous subgroups. Kraepelin (1899) already distinguished more florid symptoms from those that were marked by losses or deficits; the latter were responsible for the term “dementia praecox”. Bleuler (1911) is well known and influential in Anglo-American psychiatry and is often viewed as a forefather of the distinction between positive and negative schizophrenia. For example, Pfohl and Andreasen (1986), Crow (1982), and Sommers (1985) see present-day negative symptoms as a reduced version of Bleuler’s fundamental or basic symptoms (disturbances of association and affect, ambivalence, and autism).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abels D: Der Konzentrations-Verlaufs-Test K-V-T (the course-of-concentration-test, 2nd ed). Berlin, Springer, 1961
Allen HA: Dichotic monitoring and focussed versus divided attention in schizophrenia. British Journal of Clinical Psychology 21: 205–212, 1982
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, third edition, revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987
Anath J, Chadirian A: Drug induced mood disorder. International Pharmacopsychiatry 15: 58–73, 1980
Andreasen NC: Negative symptoms in schizophrenia: definition and reliability. Archives of General Psychiatry 39: 784–788, 1982
Andreasen NC: Positive vs. negative schizophrenia: a critical evaluation. Schizophrenia Bulletin 11: 380–389, 1985
Andreasen NC Akiskal HS: The specificity of Bleulerian and Schneiderian symptoms: a critical re-evaluation. Psychiatric Clinics of North America 6: 41–54, 1983
Andreasen NC, Flaum M: Schizophrenia: the characteristic symptoms. Schizophrenia Bulletin 17: 27–49, 1991
Andreasen NC, Flaum M, Swayze VW, Tyrrell G, Arndt S: Positive and negative symptoms in schizophrenia. Archives of General Psychiatry 47: 615–621, 1990
Andreasen NC, Olsen SA: Negative vs. positive schizophrenia: definition and validation. Archives of General Psychiatry 39: 789–794, 1982
Andreasen NC, Olsen SA, Dennert JW, Smith JW: Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. American Journal of Psychiatry 139: 297–302, 1982
Ayd FJ: The depot fluphenazines: a reappraisal after 10 years’ clinical experience. American Journal of Psychiatry 132: 491–500, 1975
Arbeitsgemeinschaft für Methodik and Dokumentation in der Psychiatrie AMDP: Das AMDP-System: Manual zur Dokumentation psychiatrischer Befunde (The AMDP-System: Manual for the Assessment and Documentation of Psychopathology, 4th ed.). Berlin, Springer, 1981
Asaranow RF, MacCrimmon DJ: Residual performance deficit in clinically remitted schizophrenics: a marker of schizophrenia? Journal of Abnormal Psychology 87: 597–608, 1978
Asaranow RF, MacCrimmon DJ: Span of apprehension deficits during postpsychotic stages of schizophrenia. Archives of General Psychiatry 38: 1006–1011, 1981
Asaranow RF, MacCrimmon DJ: Attention/information processing, neuropsychological functioning, and thought disorder during the acute and partial recovery phases of schizophrenia: A longitudinal study. Psychiatry Research 7: 309–319, 1982
Beck AT: Depression Inventory. Philadelphia, Center for Cognitive Therapy, 1978
Beck AT, Rush AJ, Shaw BF, Emery G: Kognitive Therapie der Depression. München, Urban & Schwarzenberg, 1981
Bilder RM, Murkherjee S, Rieder, RO, Pandurangi, AK: Symptomatic and neuropsychological components of defect states. Schizophrenia Bulletin 11: 409–417, 1985
Bleuler E: Dementia praecox oder die Gruppe der Schizophrenien (Dementia Praecox or the Group of Schizophrenias). Leipzig, Deuticke, 1911
Breier A, Wolkowitz OM, Doran AR, Roy A, Boronow J, Hommer D, Pickar D: Neuroleptic responsivity of negative and positive symptoms in schizophrenia. American Journal of Psychiatry 144: 1549–1555, 1987
Carpenter WT, Conley RR: Treatment approaches to negative symptoms. In JF Greden, R Tandon (eds): Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications (pp. 205–214). Washington, DC: American Psychiatric Press, Inc., 1991
Carpenter WT, Heinrichs DW, Alphs LD: Treatment of negative symptoms. Schizophrenia Bulletin 11: 37–49, 1985
Chaturvedi SK, Prasad Rao G., Mathai JP: Negative symptoms in schizophrenia and depression. Indian Journal of Psychiatry 27: 237–241, 1985
Ciompi L: Ist die chronische Schizophrenie ein Artefakt? Argumente und Gegenargumente (Is chronic schizophrenia an artefact? Arguments and counter-arguments). Fortschritte der Neurologie Psychiatrie 48: 237–248, 1980
Cornblatt BA, Lenzenweger MF, Dworkin, RH, Erlenmeyer-Kimling L: Positive and negative schizophrenic symptoms, attention, and information processing. Schizophrenia Bulletin 11: 397–407, 1985
Crow TJ: Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280: 1–9, 1980
Crow TJ: The biology of schizophrenia. Experientia 38: 1275–1282
Crow TJ, Cross AJ, Johnstone ECD, Owen F: Two syndromes in schizophrenia and their pathogenesis. In: Henn FA, Nasrallah HA (eds.): Schizophrenia as a Brain Disease, pp. 196–234. New York, Oxford University Press, 1982
Dixon WJ: BMDP Statistical Software. Berkley, University of California Press, 1985
Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 35: 837–844, 1978
Goffmann E: Asylums. New York, Anchor Books, 1961
Goetz KL, van Kammen DP: Computerized axial tomography scans and subtypes of schizophrenia: a review of the literature. Journal of Nervous and Mental Disease 174: 208–213
Goldberg SC: Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophrenia Bulletin 11: 453–456, 1985
Green M, Walker E: Attentional performance in positive and negative schizophrenia. Journal of Nervous and Mental Disease 174: 208–213, 1986
Green M, Walker E: Neuropsychological performance and positive and negative symptoms in schizophrenia. Journal of Abnormal Psychology 94: 368–377, 1985
Green M, Walker E: Susceptibility to backward masking in schizophrenics with positive and negative symptoms. American Journal of Psychiatry 141: 1273–1275, 1984
Gross G, Huber G, Klosterkötter J, Linz M: Bonner Skala für die Beurteilung von Basissymptomen BSABS (The Bonn Scale for the Assessment of Basic Symptoms). Berlin, Springer, 1987
Gruhle HW: Die Psychologie der Dementia praecox (The psychology of dementia praecox). Zentralblatt für Neurologie 78: 454–471, 1922
Gruhle HW: Psychologie der Schizophrenie (Psychology of Schizophrenia). In: Berze J, Gruhle HW (eds): Psychologie der Schizophrenie (Psychology of Schizophrenia), pp. 73–168. Berlin, Springer, 1929
Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23: 56–62, 1960
Harvey PD, Earle-Boyer EA, Levinson JC: Cognitive deficits and thought disorder: a retest study. Schizophrenia Bulletin 14: 57–65, 1988
Harvey PC, Serper MR: Linguistic and cognitive failures in schizophrenia. Journal of Nervous and Mental Disease 178: 487–493, 1990
Helwig J: Einführung in das SAS. transl. by G. Frenzel. Cary, North Carolina: SAS Institute Inc.
Hemsley DR: Information processing and schizophrenia. In: Straube ER, Hahlweg K (eds): Schizophrenia. Concepts, Vulnerability, and Intervention, pp. 59–76. Springer, Berlin, 1990
Hogarty GE, Muntzer MR: Pharmacogenic depression among schizophrenic outpatients: a failure to substantiate. Journal of Clinical Psychopharmacology 4: 17–24, 1984
Huber G, Gross G, Schüttler R: Schizophrenie. Eine verlaufs-und sozialpsychiatrische Langzeitstudie (Schizophrenia. A long-term study of course and social psychiatric effects). Berlin, Springer, 1979
Janzarik W: Dynamische Grundkonstellationen in endogenen Psychosen (Dynamic basic constellations of endogenous psychoses). Berlin, Springer, 1959
Janzarik W: Schizophrene Verläufe. Eine strukturdynamische Interpretation (Schizophrenic courses. A structural-dynamic interpretation). Berlin, Springer, 1968
Johnson DAW (1981). Studies of depressive symptoms in schizophrenia: I. The prevalence of depression and its possible causes. British Journal of Psychiatry 139: 89–93, 1981
Johnson J: Depressive changes after fluphenazine treatment. British Medical Journal 3: 718, 1969
Kane J, Honigfeld G, Singer J, Meltzer H, & the Clozapin Collaborative Study Group (1988). Clozapine for the treatment-resistent schizophrenic. Archives of General Psychiatry 45: 789–796, 1988
Johnstone EC, Crow TJ, Frith CD, Camey MWP, Price JS: Mechanisms of the antipsychotic effect in the treatment of acute schizophrenia. Lancet I: 848–851, 1978
Kay SR: Longitudinal course of negative symptoms in schizophrenia. In: Greden JF, Tandon R (eds): Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications, pp. 21–40. Washington DC, American Psychiatric Press, 1991
Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophrenia Bulletin 13: 152–160, 1987
Kayton L, Beck J, Koh S: Postpsychotic state, convalescent environment, and therapeutic relationship in schizophrenic outcome. American Journal of Psychiatry 133: 1269–1274, 1976
Kendell RE: The Role of Diagnosis in Psychiatry. Osney Mead, Oxford, Blackwell Scientific Publications, 1975
Kick AH: Psychopathologie and Verlauf der postakuten Schizophrenie (Psychopathology and Course of Postacute Schizophrenia). Berlin, Springer, 1991
Kitamura T, Suga R: Depressive and negative symptoms in major psychiatric disorders. Comprehensive Psychiatry 32: 88–94, 1991
Klosterkötter J: Basissymptome and Endphänomene der Schizophrenie (Basic symptoms and final phenomena of schizophrenia). Berlin, Springer, 1988
Knight RA, Elliot D, Freedman, E: Short term visual memory in schizophrenics. Journal of Abnormal Psychology 94: 427–443, 1985
Knight RA, Elliot D, Roff DJ, Watson CG: Concurrent and predictive validity of components of disordered thinking. Schizophrenia Bulletin 12: 427–446, 1986
Knights A, Hirsch SR: “Revealed” depression and drug treatment for schizophrenia. Archives of General Psychiatry 38: 806–811, 1981
Kraepelin E: Psychiatrie, 6th ed., Leipzig, Barth, 1899
Kulhara P, Chadda R: A study of negative symptoms in schizophrenia and depression. Comprehensive Psychiatry 28: 229–235, 1987
Lewine RJJ, Fogg L, Meltzer HY: Assessment of negative and positive symptoms in schizophrenia. Schizophrenia Bulletin 9: 368–376, 1983
Liddle PF, Morris DL: Schizophrenic syndromes and frontal lobe performance. British Journal of Psychiatry 158: 340–345, 1991
Marjot DH: Depression following fluphenazine treatment. British Medical Journal 3: 780, 1969
Moller HJ, von Zerssen D: Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophrenia Bulletin 8: 109–117, 1982
Mundt Ch, Fiedler P, Pracht B, Rettich R: (1985). InSka (Intentionalitätsskala)—ein neues psychometrisches Instrument zur quantitativen Erfassung der schizophrenen Residualsymptomatik (InSka—a new questionnaire for the quantitative registration of schizophrenic residual symptomatology). Nervenarzt 56: 146–149, 1985
Mundt Ch, Kasper S: Zur Schizophreniespezifität von negativen and Basissymptomen (specifity of negative and basic symptoms in schizophrenia). Nervenarzt 58: 489–495, 1987
Mundt Ch, Kasper S, Huerkamp M: The diagnostic specificity of negative symptoms and their psychopathological context. British Journal of Psychiatry 155 (Suppl 7): 32–36, 1989
Nestadt G, McHugh PR: The frequency of and specifity of some “negative” symptoms. In: Huber G (ed): Basisstadien endogener Psychosen and das Borderline-Problem, pp. 183–193. Stuttgart, Schattauer, 1985
Nuechterlein KH, Edell WS, Norris M, Dawson ME: Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophrenia Bulletin 12: 408–426, 1986
Nuechterlein KH, Zaucha KM:Processing abnormalities in patients and high-risk children. In: Straube ER, Hahlweg K (eds): Schizophrenia. Concepts, Vulnerability, and Intervention, pp. 77–96. Springer, Berlin, 1990
Owens DGC, Johnstone EC: The disabilities of chronic schizophrenia—their nature and the factors contributing to their development. British Journal of Psychiatry 136: 384–395, 1980
Pfohl B, Andreasen N: Schizophrenia: diagnosis and classification. In: Hales FA (ed): Psychiatry update, vol. 5, pp. 38–51. Washington DC, American Psychiatric Press, 1986
Pfohl B, Winokur G: The micropsychopathology of hebephrenic/catatonic schizophrenia. Journal of Nervous and Mental Disease 171: 296–300, 1983
Pfohl B, Winokur G: The evaluation of symptoms in institutionalized hebephrenic/catatonic schizophrenics. British Journal of Psychiatry 141: 567–572, 1982
Place J, Gilmore GC: Perceptual organization in schizophrenia. Journal of Abnormal Psychology 89: 409–418, 1980
Plananski K, Johnston R: Depressive syndrome in schizophrenia. Acta Psychiatrica Scandinavica 57: 207–218, 1978
Pogue-Geile MF, Harrow M: Negative and positive symptoms in schizophrenia and depression: a follow up. Schizophrenia Bulletin 10: 371–387, 1984
van Putten T, May PRA: “Akinetic depression” in schizophrenia. Archives of General Psychiatry 35: 1101–1107, 1978
Rifkin A, Quitkin F, Klein SF: Akinesia, a poorly recognized drug-induced extrapyramidal behaviour disorder. Archives of General Psychiatry 32: 672–674, 1975
Rosen WG, Mohs RC, Johns CA, Small NS, Kendler KS, Horvath TB, Davis KL: Positive and negative symptoms in schizophrenia. Psychiatry Research 13: 277–284, 1984
Rosvold HE, Mirsky A, Sarason I, Bransome ED, Beck LH: A continuous performance test of brain damage. Journal of Consulting Psychology 20: 343–350, 1956
Salzinger K, Portnoy S, Feldmann RS: Communicability deficit in schizophrenics resulting from a more general deficit. In: Schwartz S (ed): Language and Cognition in Schizophrenia, pp. 35–53. Hillsdale, Erlbaum, 1978
Salzinger K, Portnoy S, Feldmann RS: Verbal behavior of schizophrenics and normal subjects. Annals of the New York Academy of Sciences 105: 845–860, 1964
Sass H: The historical evolution of the concept of negative symptoms in schizophrenia. British Journal of Psychiatry 155 (Suppl 7): 26–31, 1989
Schneider K: Psychischer Befund and psychiatrische Diagnose (Mental state and psychiatric diagnosis). Leipzig, Thieme, 1939
Segal M, Ropschitz DH: Depressive changes after fluphenazine treatment. British Medical Journal 4: 169, 1969
Shanfield S, Tucker GJ, Harrow M, Detre T: The schizophrenic patient and depressive symptomatology. Journal of Nervous and Mental Disease 151: 203–210, 1970
Silverstein ML, Arzt, AT: Neuropsychological dysfunction in schizophrenia. Journal of Nervous and Mental Disease 173: 341–346, 1985
Siris SG, Rifkin A, Reardon GT, Endicott J, Pereira DH, Hayes R, Casey E: Course-related depressive syndromes in schizophrenia. American Journal of Psychiatry 141: 1254–1257, 1983
Sommers E: “Negative symptoms”: conceptual and methodological problems. Schizophrenia Bulletin 11: 364–378, 1985
Spring B, Lemon M, Fergeson P: Vulnerabilities to schizophrenia: information-processing markers, In: Straube ER, Hahlweg K (eds): Schizophrenia. Concepts, Vulnerability, and Intervention, pp. 97–114. Berlin, Springer, 1990
Strauss JS, Carpenter WT, Bartko JJ: The diagnosis and understanding of schizophrenia, II: speculations upon the process that underlie schizophrenic symptoms and signs. Schizophrenia Bulletin 11: 61–76, 1974
Strian F, Heger R, Klicpera C: The time structure of depressive mood in schizophrenic patients. Acta Psychiatrica Scandinavica 65: 66–73, 1982
Süllwold L, Huber G: Schizophrene Basisstörungen (Basic disturbances in schizophrenia). Berlin, Springer, 1986
Tandon R, Goldman RS, Goodson J, Greden JF: Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia. Biological Psychiatry 27: 1323–1326, 1990
Tandon R, Greden JF: Conclusion: is integration possible? In: Greden JF, Tandon R (eds): Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications, pp. 233–239. Washington DC, American Psychiatric Press, 1991
Taylor WL: Cloze procedure: a new tool for measuring readability. Journalism Quarterly 30: 415–433, 1953
Wagner M: Experimentelle Verfahren zur Aufmerksamkeitsprüfung (EVA): CPT and SAT (Experimental measures of attention: CPT and SAT). München, Psychiatrische Universitätsklinik, 1989
Weiner RU, Opler LA, Kay SR, Merriam AE, Papouchis M: Visual information processing in positive, mixed, and negative schizophrenic syndromes. Journal of Nervous and Mental Disease 178: 616–626, 1990
Wing JK: A standard form of psychiatric Present-State Examination and a method for standardizing the classification of symptoms. In: Hare EH, Wing JK (eds): Psychiatric Epidemiology: An International Symposium, pp. 93–108. London, Oxford University Press, 1970
Wing JK: Schizophrenia: Towards a New Synthesis. London, Academic Press, 1978
Wing JK, Brown GW: Institutionalization and Schizophrenia. Cambridge, Cambridge University Press, 1970
Wohlberg GW, Kornetsky C: Sustained attention in remitted schizophrenics. Archives of General Psychiatry 28: 533–537, 1973
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag, New York
About this chapter
Cite this chapter
Barnett, W., Mundt, C. (1992). Are Latent Thought Disorders the Core of Negative Schizophrenia?. In: Spitzer, M., Uehlein, F., Schwartz, M.A., Mundt, C. (eds) Phenomenology, Language & Schizophrenia. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9329-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9329-0_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9331-3
Online ISBN: 978-1-4613-9329-0
eBook Packages: Springer Book Archive